Trials / Active Not Recruiting
Active Not RecruitingNCT00048958
Cytogenetic Studies in Acute Leukemia and Multiple Myeloma
Cytogenetic Studies in Acute Leukemia and Multiple Myeloma: Companion to CALGB Treatment Studies For Previously Untreated Acute Myeloid Leukemia (AML), Acute Lymphoblastic Leukemia (ALL), Myelodysplastic Syndrome (MDS) or Multiple Myeloma (MM) Patients
- Status
- Active Not Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 9,000 (estimated)
- Sponsor
- Alliance for Clinical Trials in Oncology · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Chromosomal analysis or the study of genetic differences in patients previously untreated with AML, ALL, MDS or MM may be helpful in the diagnosis and classification of disease. It may also improve the ability to predict the course of disease and the selection of therapy. Institutions must have either an Alliance-approved cytogeneticist or an agreement from an Alliance-approved main member cytogenetics laboratory to enroll a patient on CALGB 8461. The Alliance Approved Institutional Cytogeneticists list is posted on the Alliance for Clinical Trials in Oncology website.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| GENETIC | cytogenetic analysis |
Timeline
- Start date
- 1984-06-01
- Primary completion
- 2100-01-01
- First posted
- 2003-01-27
- Last updated
- 2024-07-31
Locations
137 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00048958. Inclusion in this directory is not an endorsement.